National Centre for Clinical Research on Emerging Drugs
About
In recent decades, authors affiliated with National Centre for Clinical Research on Emerging Drugs have published 1.5k papers, which have received a total of 76.8k indexed citations.
Scholars at this organization have produced 682 papers in Epidemiology, 572 papers in Infectious Diseases and 323 papers in Virology on the topics of Prevention and Treatment of HIV/AIDS Infection (433 papers), HIV Research and Treatment (320 papers) and HIV, Drug Use, Sexual Risk (306 papers). Their work is cited by papers focused on Epidemiology (31.9k citations), Infectious Diseases (25.9k citations) and Virology (15.6k citations). Authors at National Centre for Clinical Research on Emerging Drugs collaborate with scholars in Australia, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of National Centre for Clinical Research on Emerging Drugs's most productive authors include John Kaldor, Matthew Law, David A. Cooper, Gregory J. Dore and Andrew E. Grulich
In The Last Decade
Explore institutions with similar magnitude of impact
Top fields impacted by scholars at Aarhus Business College Top fields impacted by scholars at ARC Centre of Excellence in Advanced Molecular Imaging Top countries scholars at Denver VA Medical Center are collaborate with authors working in Top countries scholars at National Institute for Nanotechnology are collaborate with authors working in Top qs scholars at Institute of Arctic and Alpine Research are publish in journals categorized as Top fields scholars at New York State Office for People With Developmental Disabilities are working on Top journals impacted by scholars at Institute for Marine Biosciences Top fields scholars at Max Planck Institute of Biophysics are working on